Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2011 - 2026)

Bausch Health Companies (BHC) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $295.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 3.28% year-over-year to $295.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 4.31% YoY), and the FY2025 full-year result was $1.2 billion, down 4.66% from the prior year.
• Depreciation & Amortization (CF) climbed to $295.0 million in Q1 2026, from $290.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $360.0 million in Q4 2022 to a low of $290.0 million in Q4 2025.
• A 5-year average of $319.3 million and a median of $318.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) decreased 14.11% in 2022 and advanced 6.98% in 2024, its largest moves.
• Tracing BHC's Depreciation & Amortization (CF) over 5 years: stood at $360.0 million in 2022, then decreased by 8.61% to $329.0 million in 2023, then slipped by 6.69% to $307.0 million in 2024, then decreased by 5.54% to $290.0 million in 2025, then gained by 1.72% to $295.0 million in 2026.
• Business Quant data shows BHC's Depreciation & Amortization (CF) at $295.0 million in Q1 2026, $290.0 million in Q4 2025, and $306.0 million in Q3 2025.